Molecular epidemiology of VIM-4 metallo-β-lactamase-producing Pseudomonas sp. isolates in Hungary

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 4220-4223

  Libisch, Balázs ^a   Muzslay, Mónika ^a   Gacs, Mária ^a   Minárovits, János ^a   Knausz, Márta ^b   Watine, Joseph ^c   Ternák, Gábor ^d   Kenéz, Éva ^d   Kustos, Ildikó ^e   Rókusz, László ^f   Széles, Klára ^g   Balogh, Boglárka ^a   Füzi, Miklós ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b Aladar Petz County Teaching Hospital   (Hungary)

^c HÔPITAL DU BOCAGE   (France)

^d Baranya County Hospital   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

^f Central Military Hospital Budapest   (Hungary)

^g Department of Epidemiology   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CLINICAL ARTICLE; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUNGARY; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS; PULSED FIELD GEL ELECTROPHORESIS;

BASE SEQUENCE; BETA-LACTAMASES; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; HUNGARY; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 33845246552     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00300-06     Document Type: Article

References (23)

1. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
2. Crespo, M. P., N. Woodford, A. Sinclair, M. E. Kaufmann, J. Turton, J. Glover, J. D. Velez, C. R. Castaneda, M. Recalde, and D. M. Livermore. 2004. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J. Clin. Microbiol. 42:5094-5101.
3. Fiett, J., A. Baraniak, A. Mrowka, M. Fleischer, Z. Drulis-Kawa, L. Naumiuk, A. Samet, W. Hryniewicz, and M. Gniadkowski. 2006. Molecular epidemiology of acquired-metallo-β-lactamase-producing bacteria in Poland. Antimicrob. Agents Chemother. 50:880-886.
4. Grattard, F., O. G. Gaudin, B. Pozzeto, A. Ris, and A. D. Mbida. 1993. Genotypic homogeneity of nosocomial Pseudomonas aeruginosa O12 strains demonstrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns. Eur. J. Clin. Microbiol. Infect. Dis. 12:57-61.
5. Johan Béla National Public Health Institute. 1997. Antibiotic susceptibility of the most important gram-negative bacteria, p. 159-173. In The 1996 annual report of the Johan Béla National Public Health Institute. Johan Béla National Public Health Institute, Budapest, Hungary. (In Hungarian.)
6. VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058.
7. VIM-4 type metallo-β-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrob. Agents Chemother. 48:3576-3578.
8. Mifsud, J. A., J. Watine, B. Picard, J. C. Charet, C. Solignac-Bourrel, and T. L. Pitt. 1997. Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. J. Hosp. Infect. 36:105-116.
9. VIM-4 cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother. 53:451-456.
10. Pitt, T. L., D. M. Livermore, D. Pitcher, A. C. Vatopoulos, and N. J. Legakis. 1989. Multiresistant serotype O12 Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiol. Infect. 103:565-576.
11. Poh, C. L., C. C. Yeo, and L. Tay. 1992. Genome fingerprinting by pulsedfield gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains. Eur. J. Clin. Microbiol. Infect. Dis. 11:817-822.
12. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
13. Réseau Épidémiologique des Utilisateurs du Système SIR. 2001. Le portage prolongé et la diffusion clonale interhospitaliére des Pseudomonas aeruginosa multirésistants de sérotype O12 sont-ils liés? Étude multicentrique. Pathol. Biol. 49:620-623.
14. Riccio, M. L., L. Pallecchi, J. D. Docquier, S. Cresti, M. R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G. M. Rossolini. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110.
15. VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45: 1249-1253.
16. Rossolini, G. M. 2005. Acquired metallo-β-lactamases: an increasing clinical threat. Clin. Infect. Dis. 41:1557-1558.
17. Scott, F. W., and T. L. Pitt. 2004. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 53:609-615.
18. Speijer, H., P. H. Savelkoul, M. J. Bonten, E. E. Stobberingh, and J. H. Tjhie. 1999. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J. Clin. Microbiol. 37:3654-3661.
19. Struelens, M. J., V. Schwam, A. Deplano, and D. Baran. 1993. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J. Clin. Microbiol. 31:2320-2326.
20. Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
21. Yan, J. J., J. J. Wu, S. H. Tsai, and C. L. Chuang. 2004. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn. Microbiol. Infect. Dis. 49:5-11.
22. Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
23. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.